A live-attenuated Zika virus vaccine that protected mice and non-human primates might also kill human glioblastoma cells, according to research published in mBio. Zika virus targets fetal neural progenitor cells but is less harmful to differentiated, healthy brain cells, and the vaccine killed lab-grown glioblastoma cells as well as human glioblastoma cells transplanted into mouse brains.
Zika virus vaccine validated in monkeys kills glioblastoma cells
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.